Table 1: Results of breast tissue microarray immunohistochemical analysis of gpC1 expression.
|
|
|
gpC1 Positive (%) |
gpC1 Negative (%) |
gpC1 Diffuse or focal strong positive (%) |
|
Non-neoplastic |
NB-NC (n = 6) |
0(0) |
6(100%) |
0(0%) |
|
breast tissue |
NB-C (n = 7) |
2(28.6%) |
5(71.4%) |
1(14.3%) |
|
|
Non-neoplastic total |
2(15.4%) |
11(84.6%) |
1(7.7%) |
|
Neoplastic |
DCIS-L (n = 7) |
5(71.4%) |
2(28.6%) |
2(28.6%) |
|
breast tissue |
DCIS-H (n = 7) |
4(57.1%) |
3(42.9%) |
2(28.6%) |
|
|
DCIS total |
9(64.3%) |
5(35.7%) |
4(28.6%) |
|
|
IDC-L (n = 6) |
5(83.3%) |
1(16.7%) |
3(50%) |
|
|
IDC-H (n = 7) |
6(85.7%) |
1(14.3%) |
2(28.6%) |
|
|
IDC total |
11(84.6%) |
2(15.4%) |
5(38.5%) |
|
|
ILC (n = 5) |
3(60%) |
2(40%) |
2(40%) |
|
|
LNM (n = 7) |
3(42.9%) |
4(57.1%) |
1(14.3%) |
|
|
Neoplastic total |
26(66.7%) |
13(33.3%) |
12(30.8%) |
NB-NC: Non-neoplastic breast tissue from patients without breast carcinoma; NB-C: Non-neoplastic breast tissue from breast carcinoma patients; DCIS-L: Ductal carcinoma in situ, low grade; DCIS-H: Ductal carcinoma in situ, high grade; IDC-L: Invasive ductal carcinoma, grade 1 or 2; IDC-H: Invasive ductal carcinoma, grade 3; ILC: Invasive lobular carcinoma; LNM: Breast carcinoma metastatic to regional lymph nodes.